Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Dec 7;141(11):839-45.
doi: 10.7326/0003-4819-141-11-200412070-00007.

Negative D-dimer result to exclude recurrent deep venous thrombosis: a management trial

Suman W Rathbun  1 , Thomas L Whitsett, Gary E Raskob
Affiliations
Clinical Trial

Negative D-dimer result to exclude recurrent deep venous thrombosis: a management trial

Suman W Rathbun et al. Ann Intern Med. .

Abstract

Background: All of the available diagnostic tests for deep venous thrombosis (DVT) have limitations for excluding acute recurrent DVT. Measurement of plasma d-dimer by using an automated quantitative assay may be useful as a rapid exclusion test in patients with suspected recurrent DVT.

Objective: To test the safety of withholding additional diagnostic testing and heparin treatment in patients who have a negative d-dimer result at presentation (using the automated quantitative assay STA-Liatest D-di), regardless of their symptoms.

Design: Prospective cohort study.

Setting: Academic medical center in the United States.

Patients: 300 consecutive patients with suspected recurrent DVT.

Intervention: Patients underwent d-dimer testing at presentation. In patients with negative D-dimer results, heparin therapy was withheld, and no further diagnostic testing for DVT was done as part of the initial evaluation. Patients with positive D-dimer results underwent compression ultrasonography.

Measurements: The primary outcome measure was a diagnosis of new symptomatic venous thromboembolism confirmed by diagnostic testing during the 3-month follow-up period.

Results: Of the 300 study patients, the d-dimer result was negative at presentation in 134 patients (45%; negative cohort) and positive at presentation in 166 patients. Of the 166 patients, compression ultrasonography documented new DVT in 54 patients. Compression ultrasonography findings were normal in 79 patients and were inconclusive in 33 patients. After 3 months of follow-up, 1 of 134 patients in the negative cohort had confirmed venous thromboembolism (0.75% [95% CI, 0.02% to 4.09%]). Venous thromboembolism on follow-up could not be definitively excluded in 5 patients with recurrent leg symptoms and in 1 patient who died. If these patients are considered to have venous thromboembolism, the incidence during the 3-month follow-up period would be 6.0% (CI, 2.6% to 11.4%) (8 of 134 patients).

Limitations: There is no accepted diagnostic reference standard for recurrent DVT. The precision of the estimate of the incidence of venous thromboembolism on follow-up and the generalizability to settings other than an academic health center should be evaluated.

Conclusions: Measurement of plasma d-dimer by using the automated quantitative assay STA-Liatest D-di seems to provide a simple method for excluding acute recurrent DVT in symptomatic patients.

PubMed Disclaimer

Conflict of interest statement

Potential Financial Conflicts of Interest: Grants received: S.W. Rathbun (Diagnostica Stago); Other: S.W. Rathbun (reagents for d-dimer were provided by Diagnostica Stago).

Figures

Figure
Figure. Study protocol for patients with suspected recurrent deep venous thrombosis (DVT)
LMWH = low-molecular-weight heparin; PE = pulmonary embolism.
See this image and copyright information in PMC

Summary for patients in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ., 3rd Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158:585–93. [PMID: 9521222] - PubMed
    1. Anderson FA, Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151:933–8. [PMID: 2025141] - PubMed
    1. Koopman MM, Buller HR, ten Cate JW. Diagnosis of recurrent deep vein thrombosis. Haemostasis. 1995;25:49–57. [PMID: 7896222] - PubMed
    1. Hull RD, Carter CJ, Jay RM, Ockelford PA, Hirsch J, Turpie AG, et al. The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge. Circulation. 1983;67:901–6. [PMID: 6825247] - PubMed
    1. Huisman MV, Beaumont-Koopman MM. The diagnosis of recurrent deep-vein thrombosis. In: Hull Rd, Raskob GE, and Pineo GF, eds. Venous Thromboembolism: An Evidence-Based Atlas. Armonk, NY: Futura Publishing; 1996:148-XXX.

Publication types

Substances